Louisiana 2024 Regular Session

Louisiana House Bill HB839

Introduced
4/2/24  
Introduced
4/2/24  
Refer
4/3/24  
Refer
4/3/24  
Report Pass
4/16/24  
Report Pass
4/16/24  
Engrossed
4/24/24  
Refer
4/29/24  
Report Pass
5/8/24  
Report Pass
5/8/24  
Enrolled
5/24/24  
Enrolled
5/24/24  
Chaptered
6/3/24  

Caption

Provides relative to step therapy or fail first protocols (EN INCREASE SG EX See Note)

Impact

The bill's provisions are expected to enhance patient care by removing barriers associated with step therapy requirements for ventilators. By explicitly forbidding insurance plans from subjecting ventilator prescriptions to step therapy or fail first criteria, it could potentially lead to quicker and more direct access for patients needing these devices. Additionally, the enactment of this bill creates a precedent that aligns patient care priorities with healthcare regulations, promoting a more patient-centered approach in Louisiana's healthcare system.

Summary

House Bill 839 amends existing health coverage regulations specifically addressing step therapy or fail first protocols utilized by health insurance plans. The bill mandates that any health plan employing such protocols must also provide coverage for prescribed ventilators without imposing these protocols when specific conditions are met. These conditions include scenarios where the ventilator requires substantial servicing or when alternative treatments may pose greater risks to the patient, based on clinical evidence. This legislative move aims to ensure that patients have timely access to critical medical equipment necessary for their healthcare needs.

Sentiment

The sentiment surrounding HB 839 appears largely supportive, particularly among healthcare advocates who argue that easing restrictions on ventilator access fosters better health outcomes for vulnerable patients. The legislative discussions suggest a recognition of the importance of timely medical interventions and an acknowledgment of the unique challenges faced by patients requiring ventilatory support. However, there may still be concerns regarding the implications of this change on insurance plans and the potential for higher costs.

Contention

While the bill received unanimous support in the voting process—indicating broad bipartisan agreement—the discussion may have included diverse opinions on the potential implications for health insurance practices and costs. Notable points of contention likely revolved around how insurers would adapt to these changes and the administrative impact on healthcare systems providing ventilator services. The lack of public dissent in the voting process could indicate a shared recognition of the bill's necessity, despite any underlying concerns from insurance entities regarding the implications of such legislative changes.

Companion Bills

No companion bills found.

Previously Filed As

LA HB403

Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols

LA SB110

Provides for patient's right to prompt coverage. (8/1/23) (EN INCREASE SG EX See Note)

LA SB164

Provides relative to prior authorization for services, procedures, and pharmaceuticals. (gov sig) (RE1 INCREASE SG EX See Note)

LA HB186

Provides relative to health insurance coverage for standard fertility preservation services (EN INCREASE SG EX See Note)

LA HB272

Provides relative to maternity support services of doulas (EN INCREASE SG EX See Note)

LA SB186

Provides relative to the Occupational Therapy Licensure Compact. (1/1/24) (EN SEE FISC NOTE SG RV See Note)

LA HB435

Provides relative to medicaid coverage of chimeric antigen receptor T-cell therapy (EN SEE FISC NOTE GF EX See Note)

LA HB593

Provides relative to cemeteries (EN INCREASE SG EX See Note)

LA HB17

Provides relative to the regulation of cannabis (OR INCREASE SG EX See Note)

LA SB104

Provides for health insurance coverage of genetic testing for diseases and other medical conditions. (8/1/23) (EN INCREASE GF EX See Note)

Similar Bills

No similar bills found.